Search - tctmd.com

Displaying 41 - 60 of 126

Sort: Relevancy | Date

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

AHA Revamps Life’s Simple 7, Adding Sleep to Create ‘Essential 8’

Todd Neale

June 29, 2022

News Daily News

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Michael O'Riordan

March 15, 2022

News Daily News

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

L.A. McKeown

March 01, 2022

News Daily News

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Yael L. Maxwell

February 22, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

Cumulative Burden of LDL Cholesterol Increases CHD Risk

Michael O'Riordan

September 23, 2021

News Daily News

Many Resuscitated Arrests Don’t Have an Underlying Cardiac Cause

Todd Neale

May 12, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

L.A. McKeown

August 04, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

News Daily News

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Yael L. Maxwell

April 28, 2020

News Daily News

Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment

Yael L. Maxwell

February 12, 2020

Advertisement

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Top General Cardiology and Prevention News of 2022

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

High Lp(a) May Predict Risk of CV and Limb Events in PAD

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

AHA Revamps Life’s Simple 7, Adding Sleep to Create ‘Essential 8’

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Cumulative Burden of LDL Cholesterol Increases CHD Risk

Many Resuscitated Arrests Don’t Have an Underlying Cardiac Cause

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content